Non-viral vectors for gene-based therapy | Nature Reviews Genetics
Ensuring a future for gene therapy for rare diseases | Nature Medicine
CRISPR in cancer biology and therapy | Nature Reviews Cancer
Overcoming cellular barriers for RNA therapeutics | Nature Biotechnology
Viral vector platforms within the gene therapy landscape | Signal Transduction and Targeted Therapy
The NIH Somatic Cell Genome Editing program | Nature
Volume 15 Issue 3, September 2021
The therapeutic landscape for cells engineered with chimeric antigen receptors | Nature Biotechnology
Delivering gene therapy | Feature | Chemistry World
The delivery challenge: fulfilling the promise of therapeutic genome editing | Nature Biotechnology
Disruptions in the development of cell and gene therapies
Progress and problems with the use of viral vectors for gene therapy | Nature Reviews Genetics
Considering the potential for gene-based therapy in prostate cancer | Nature Reviews Urology
Gene therapy - promises, problems and prospects | Nature
Delivery technologies to engineer natural killer cells for cancer immunotherapy | Cancer Gene Therapy
The transformative potential of HSC gene therapy as a genetic medicine | Gene Therapy
Gene therapies close in on a cure for sickle-cell disease
The once and future gene therapy | Nature Communications
Gene Therapy | Learn Science at Scitable
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene Therapy
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy | Nature Biotechnology
Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine | Gene Therapy
Gene Therapy
Realizing the promise of gene therapy through collaboration and partnering: Pfizer's view
